Healthcare Triangle Secures $1.63 Million Through Warrant Exercise Agreements

Healthcare Triangle, Inc. has executed warrant exercise agreements with accredited and institutional investors that will generate approximately $1.63 million in immediate gross proceeds for the digital transformation company. The transaction involves the exercise of existing warrants covering 812,775 shares of common stock, with the exercising holders receiving new warrants for an equal number of shares in return for their immediate cash investment. This financial maneuver represents a strategic capital raise for the healthcare technology firm as it continues to expand its digital transformation services across the healthcare and life sciences sectors.

The warrant inducement includes several key financial adjustments that make the transaction attractive to investors. The company agreed to reduce the exercise price of the existing warrants from $20.92 to $2.00 per share, making the immediate exercise economically viable for warrant holders. In exchange for exercising these warrants, investors will receive new warrants with an exercise price of $3.00 per share, creating potential for additional future capital if these new warrants are exercised. The new warrants become exercisable once stockholder approval is obtained and will remain valid for five years from that approval date.

This financing transaction occurs as Healthcare Triangle continues to build its position in the healthcare technology market. The company specializes in helping healthcare organizations improve outcomes through better utilization of data and information technologies. Their services include cloud solutions, security and compliance, data lifecycle management, and healthcare interoperability, all critical areas as the healthcare industry undergoes significant digital transformation. The immediate $1.63 million in proceeds, before deducting placement agent fees and offering expenses, provides working capital to support these initiatives.

WallachBeth Capital served as the sole placement agent for the warrant inducement transaction, facilitating the agreements between Healthcare Triangle and the exercising warrant holders. The transaction closed on October 2, 2025, following the announcement, with the company emphasizing that the press release does not constitute an offer to sell or solicitation to buy securities in jurisdictions where such actions would be unlawful prior to proper registration or qualification. This capital infusion comes at a time when healthcare technology companies are increasingly seeking funding to support innovation and expansion in a rapidly evolving digital healthcare landscape.